GleamWall
中文EN

MGNX MACROGENICS INC

Pharmaceutical Preparations · Nasdaq · SEC CIK 1125345 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY22.8%
TTM net income YoY32.1%
TTM EPS YoY33.9%
Revenue 3-yr CAGR-2.1%
Net income 3-yr CAGR—

Margins

Gross margin—
Operating margin-70.2%
Net margin-45.4%
FCF margin-36.4%
EBITDA margin-66.4%

Returns

ROE-111.8%
ROA-17.5%
ROIC (approx.)—
Asset turnover0.39x

Leverage & solvency

Liabilities / assets92.1%
Debt / equity0.00x
Current ratio2.75x
Interest coverage-4.52x

Cash quality & payout

Operating cash flow / net income0.77x
Accruals ratio-3.9%
Payout ratio—
Capex / revenue1.3%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31
Income statement
Revenue$149.50M$149.96M
Cost of revenue$0$847,000
Gross profit$149.50M$149.12M
R&D expense$147.17M$177.19M
SG&A expense$39.16M$71.05M
Operating income-$72.84M-$110.58M
Interest expense$8.51M$1.11M
Pretax income-$75.29M-$66.02M
Income tax-$672,000$944,000
Net income-$74.62M-$66.97M
EBITDA-$65.67M-$103.04M
EPS (basic)-1.18-1.07
EPS (diluted)-1.18-1.07
Weighted avg. shares (diluted)63.16M62.62M
Balance sheet
Cash & equivalents$57.22M$182.84M
Receivables$427,000$4.31M
Inventory$7.91M$0
Current assets$219.94M$217.49M
PP&E, net$2.10M$18.10M
Total assets$256.85M$261.65M
Current liabilities$43.12M$55.53M
Total liabilities$201.25M$145.60M
Shareholders' equity$55.59M$116.06M
Shares outstanding63.32M62.82M
Cash flow statement
Operating cash flow-$81.04M-$68.37M
Capital expenditure$1.91M$3.71M
Free cash flow-$82.95M-$72.08M
Investing cash flow-$114.10M$149.30M
Financing cash flow$69.51M$960,000
Depreciation & amortization$7.17M$7.54M
Stock-based compensation$14.29M$29.44M

Free plan shows the latest 2 periods; Pro shows all 15 🔒

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.